1. Home
  2. CRBU vs CPHC Comparison

CRBU vs CPHC Comparison

Compare CRBU & CPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • CPHC
  • Stock Information
  • Founded
  • CRBU 2011
  • CPHC 1994
  • Country
  • CRBU United States
  • CPHC United States
  • Employees
  • CRBU N/A
  • CPHC 751
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • CPHC Services-Misc. Amusement & Recreation
  • Sector
  • CRBU Health Care
  • CPHC Consumer Discretionary
  • Exchange
  • CRBU Nasdaq
  • CPHC Nasdaq
  • Market Cap
  • CRBU 93.0M
  • CPHC 87.8M
  • IPO Year
  • CRBU 2021
  • CPHC 1994
  • Fundamental
  • Price
  • CRBU $0.77
  • CPHC $17.38
  • Analyst Decision
  • CRBU Strong Buy
  • CPHC
  • Analyst Count
  • CRBU 5
  • CPHC 0
  • Target Price
  • CRBU $10.60
  • CPHC N/A
  • AVG Volume (30 Days)
  • CRBU 1.0M
  • CPHC 1.5K
  • Earning Date
  • CRBU 05-08-2025
  • CPHC 05-08-2025
  • Dividend Yield
  • CRBU N/A
  • CPHC 1.61%
  • EPS Growth
  • CRBU N/A
  • CPHC N/A
  • EPS
  • CRBU N/A
  • CPHC 0.16
  • Revenue
  • CRBU $9,918,000.00
  • CPHC $60,605,931.00
  • Revenue This Year
  • CRBU N/A
  • CPHC N/A
  • Revenue Next Year
  • CRBU $163.34
  • CPHC N/A
  • P/E Ratio
  • CRBU N/A
  • CPHC $107.14
  • Revenue Growth
  • CRBU N/A
  • CPHC N/A
  • 52 Week Low
  • CRBU $0.66
  • CPHC $16.91
  • 52 Week High
  • CRBU $4.21
  • CPHC $24.07
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 43.66
  • CPHC 45.70
  • Support Level
  • CRBU $0.73
  • CPHC $17.00
  • Resistance Level
  • CRBU $0.91
  • CPHC $17.69
  • Average True Range (ATR)
  • CRBU 0.08
  • CPHC 0.15
  • MACD
  • CRBU 0.01
  • CPHC 0.08
  • Stochastic Oscillator
  • CRBU 24.34
  • CPHC 60.26

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About CPHC Canterbury Park Holding Corporation 'New'

Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.

Share on Social Networks: